Castagnetti F, Breccia M, Abruzzese E, Bassan R, et al. Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint. Leukemia 2025 Nov 18. doi: 10.1038/s41375-025-02796.
PMID: 41254114